Committee Hears Two Bills to Require GLP‑1 Coverage for Public Plans; Fiscal and Clinical Concerns Raised

Chairman Ruby reopened hearings on House Bill 1451 and House Bill 1452 during the House Human Services Committee on Feb. 15; both bills would require coverage of GLP‑1 class medications for chronic weight management under state public plans.

Lacey Anderson, representing Novo Nordisk, told the committee that HB 1451 would add GLP‑1 coverage to Medicaid expansion and HB 1452 would cover the same drugs for public employees through the Public Employees Retirement System (PERS) plan for a two‑year period. "14 51 is the coverage under Medicaid... This would try to help people initially before they get to that point where things are covered to then ease health care costs long term," Anderson said, describing the bills' intent to prevent severe obesity and related procedures.

Anderson described an amendment offered by Representative Nelson that raises the BMI threshold in the bills to the level for class‑2 obesity…